AAV.AI Trademark

Trademark Overview


On Monday, October 23, 2023, a trademark application was filed for AAV.AI with the United States Patent and Trademark Office. The USPTO has given the AAV.AI trademark a serial number of 98236125. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, January 15, 2025. This trademark is owned by Shape Therapeutics Inc.. The AAV.AI trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Biologic preparations for use in the treatment of genetically based diseases and disorders; Biologic preparations for medical purposes, namely, biologic preparations for gene therapy for treating genetic disorders

Provision of gene therapy services for medical treatment purposes

Medical research services, namely, developing adeno-associated virus to target specific cell types; providing information about medical and scientific research via a website, namely, information about research of adeno-associated virus to target specific cell types
aav.ai

General Information


Serial Number98236125
Word MarkAAV.AI
Filing DateMonday, October 23, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, January 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiologic preparations for use in the treatment of genetically based diseases and disorders; Biologic preparations for medical purposes, namely, biologic preparations for gene therapy for treating genetic disorders
Pseudo MarkAAV
Goods and ServicesProvision of gene therapy services for medical treatment purposes
Goods and ServicesMedical research services, namely, developing adeno-associated virus to target specific cell types; providing information about medical and scientific research via a website, namely, information about research of adeno-associated virus to target specific cell types

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 27, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 27, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 27, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShape Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events


Event DateEvent Description
Thursday, October 26, 2023NEW APPLICATION ENTERED
Friday, October 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 6, 2024ASSIGNED TO EXAMINER
Thursday, June 13, 2024NON-FINAL ACTION E-MAILED
Thursday, June 13, 2024NON-FINAL ACTION WRITTEN
Thursday, June 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, August 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, December 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 15, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, January 15, 2025FINAL REFUSAL E-MAILED
Wednesday, January 15, 2025FINAL REFUSAL WRITTEN